Stephan A. Mayer, M.D., FCCM, FNCS, is the director of Neurocritical Care and Emergency Neurology Services for Westchester Medical Center Health Network. Dr. Mayer completed a residency in neurology and a fellowship in critical care neurology at the Columbia University College of Physicians & Surgeons, where he rose to the rank of professor of neurology and built one of the nation's leading academic neurocritical care programs. Following that, he moved to the Icahn School of Medicine at Mount Sinai, where he was the Founding Director of the Institute for Critical Care Medicine. More recently, he served as the William T. Gossett Chair of Neurology for the Henry Ford Health System in Detroit, Michigan.

Dr. Mayer is a practicing neurointensivist and is considered a world leader in the field. He has published more than 280 original research articles, 190 chapters and review articles, 370 abstracts, and written or edited 10 books, including the most recent edition of Merritt’s Textbook of Neurology, considered a standard text in the field. Dr. Mayer was a founding member and past president of the Neurocritical Care Society, an international society with more than 2,700 members. He was the principal investigator of the FAST Trial, a worldwide multicenter clinical trial evaluating ultra-early hemostatic therapy for brain hemorrhage and served as principal investigator of the NIH-funded New York Presbyterian Hospital hub of the Neurological Emergencies Treatment Trials (NETT) network and the Columbia University Subarachnoid Hemorrhage Outcomes Project. His work in helping victims of severe brain injury has been featured in the Wall Street Journal, New York Times, and in the book Cheating Death, by CNN medical correspondent Dr. Sanjay Gupta.

Education

• M.D., Cornell University Medical College
• Internship, Internal Medicine, New York Presbyterian Hospital
• Residency, Neurology, Columbia University College of Physicians & Surgeons
• Fellowship, Critical Care Neurology, Columbia University College of Physicians & Surgeons

Publications

• Puissant MM, Mayer SA, Goldstein JN, et. al. "Emergency Priorities in the Treatment of Cerebral Hemorrhage: Code-Intracerebral Hemorrhage." Neurologic clinics, 43(1), (2025) 127-139. doi: 10.1016/j.ncl.2024.07.007
• Rivier CA, Renedo D, Marini S, et. al. "Sex Modifies the Severity and Outcome of Spontaneous Intracerebral Hemorrhage." Annals of neurology, (), (2024) . doi: 10.1002/ana.27123
• Watson CC, Wong S, Mayer SA, et. al. "Teaching NeuroImage: "Panda Sign" in West Nile Encephalitis." Neurology, 103(10), (2024) e209985. doi: 10.1212/WNL.0000000000209985
• Yakhkind A, Yu W, Li Q, et. al. "Correction to: Code-ICH: A New Paradigm for Emergency Interventionn." Current neurology and neuroscience reports, 24(12), (2024) 691. doi: 10.1007/s11910-024-01384-5
• Vazqez S, Das A, Spirollari E, et. al. "Inpatient Outcomes of Cerebral Venous Thrombosis in Patients With Malignancy Throughout the United States." Journal of stroke, 26(3), (2024) 425-433. doi: 10.5853/jos.2023.04098
• Rosso M, Stengl H, Scheitz JF, et. al. "Acute Myocardial Injury in Spontaneous Intracerebral Hemorrhage: A Secondary Observational Analysis of the FAST Trial." Journal of the American Heart Association, 13(17), (2024) e035053. doi: 10.1161/JAHA.124.035053
• Mayer SA, Bruder N, Citerio G, et. al. "REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage." Journal of neurosurgery, (), (2024) 1-12. doi: 10.3171/2024.4.JNS232191

View All Publications